Company profile
Roivant Sciences Ltd. Insider Trading
ROIVEvery SEC Form 4 insider trading filing for Roivant Sciences Ltd. (ROIV) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001635088
- Filings
- 331
- Insiders
- 34
- Last filing
- 2026-08-21
Activity summary
Recent insider activity is bullish. Over the last 30 days, 15 insiders purchased shares versus 8 sales. Buying was led by Sukhatme Mayukh.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Roivant Sciences Ltd. insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $420.3M.
90 day insight
Over the last 90 days, Roivant Sciences Ltd. insiders bought $6.7M (24 transactions) and sold $168.8M (26 transactions).
- Most active insider: Sukhatme Mayukh with 24 transactions totaling $61.0M.
- Largest single sale: $20.8M by Manchester Keith S on Jun 29, 2026.
Activity is mixed — buys and sales are roughly balanced.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Sukhatme Mayukh | ROIV | Option Exercise | 144,756 | $3.85 | $557K |
| Aug 21, 2026 | Sukhatme Mayukh | ROIV | Sale | 144,756 | $36.48 | $5.28M |
| Aug 21, 2026 | Sukhatme Mayukh | ROIV | Option Exercise | 144,756 | — | — |
| Aug 20, 2026 | Sukhatme Mayukh | ROIV | Sale | 17,519 | $37.30 | $653K |
| Aug 20, 2026 | Sukhatme Mayukh | ROIV | Option Exercise | 17,519 | $3.85 | $67K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ROIV" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.